Related Experiment Videos
Arterial lesions in Behçet's disease
D Saba1, H Saricaoğlu, A S Bayram
1Uludağ University Medical Faculty, Department of Thoracic and Cardiovascular Surgery, Göğüs, Kalp ve Damar Cerrahisi Ana Bilim Dali, Görükle, 16059, Bursa, Turkey. davids@uludag.edu.tr
VASA. Zeitschrift Fur Gefasskrankheiten
|August 30, 2003
Summary
Behçet's disease arterial lesions, especially pulmonary artery aneurysms, show poor prognosis. Corticosteroids effectively treat non-pulmonary arterial occlusive disease, while aneurysms require surgery or stent-grafts.
Area of Science:
- Vascular Medicine
- Rheumatology
- Immunology
Background:
- Arterial involvement is a rare but serious complication of Behçet's disease.
- This study assesses therapeutic outcomes for arterial lesions in Behçet's disease patients.
Purpose of the Study:
- To evaluate the effectiveness of various treatments for arterial lesions in Behçet's disease.
- To determine the prognosis of pulmonary artery aneurysms and non-pulmonary arterial lesions in Behçet's disease.
Main Methods:
- Retrospective evaluation of 534 Behçet's disease patients diagnosed between 1987 and 2002.
- Follow-up intervals of 3 to 6 months to monitor arterial lesions.
- Analysis of therapeutic interventions including surgery, stent-graft insertion, and immunosuppressive therapy.
Main Results:
- Arterial lesions were found in 21 patients (3.9%).
- Pulmonary artery aneurysms (PAA) had a high mortality rate, with all three surgically treated patients dying. Survivors received cyclophosphamide and corticosteroids.
- Non-pulmonary arterial lesions were treated with surgery or stent-grafts; one patient died 8 years post-intervention. Corticosteroids were successful for occlusive lesions.
Conclusions:
- Pulmonary artery aneurysms in Behçet's disease carry a poor prognosis regardless of treatment.
- High-dose corticosteroids are effective for isolated non-pulmonary arterial occlusive lesions.
- Surgery or stent-graft insertion is recommended for non-pulmonary arterial aneurysms due to high complication risks.